330 related articles for article (PubMed ID: 30683143)
1. Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis.
Fourie JJ; Meyer L; Thomas E
Parasit Vectors; 2019 Jan; 12(1):59. PubMed ID: 30683143
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
[TBL] [Abstract][Full Text] [Related]
3. A European field assessment of the efficacy of fluralaner (Bravecto
Petersen I; Chiummo R; Zschiesche E; Karas-Tecza J; Rapti D; Roepke R; Thomas E
Parasit Vectors; 2020 Jun; 13(1):304. PubMed ID: 32527282
[TBL] [Abstract][Full Text] [Related]
4. Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto
Rohdich N; Meyer L; Guerino F
Parasit Vectors; 2022 Mar; 15(1):83. PubMed ID: 35279216
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral fluralaner for the treatment of canine generalized demodicosis: a molecular-level confirmation.
Djuric M; Milcic Matic N; Davitkov D; Glavinic U; Davitkov D; Vejnovic B; Stanimirovic Z
Parasit Vectors; 2019 May; 12(1):270. PubMed ID: 31138280
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.
Heine J; Krieger K; Dumont P; Hellmann K
Parasitol Res; 2005 Oct; 97 Suppl 1():S89-S96. PubMed ID: 16228281
[TBL] [Abstract][Full Text] [Related]
7. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.
Paterson TE; Halliwell RE; Fields PJ; Louw ML; Ball G; Louw J; Pinckney R
Vet Parasitol; 2014 Oct; 205(3-4):687-96. PubMed ID: 25262617
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate) against generalised demodicosis in dogs.
Fourie JJ; Delport PC; Fourie LJ; Heine J; Horak IG; Krieger KJ
Parasitol Res; 2009 Aug; 105 Suppl 1():S115-24. PubMed ID: 19575232
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe.
Lebon W; Beccati M; Bourdeau P; Brement T; Bruet V; Cekiera A; Crosaz O; Darmon C; Guillot J; Mosca M; Pin D; Popiel J; Pomorska Handwerker D; Larsen D; Tielemans E; Beugnet F; Halos L
Parasit Vectors; 2018 Sep; 11(1):506. PubMed ID: 30201031
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis.
Beugnet F; Halos L; Larsen D; de Vos C
Parasite; 2016; 23():14. PubMed ID: 27012161
[TBL] [Abstract][Full Text] [Related]
11. Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid.
Huang HP; Lien YH
Acta Vet Scand; 2013 May; 55(1):40. PubMed ID: 23663380
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States.
Vatta AF; Myers MR; Rugg JJ; Chapin S; Pullins A; King VL; Rugg D
Vet Parasitol; 2019 Jun; 270 Suppl 1():S3-S11. PubMed ID: 30579753
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis.
Six RH; Becskei C; Mazaleski MM; Fourie JJ; Mahabir SP; Myers MR; Slootmans N
Vet Parasitol; 2016 May; 222():62-6. PubMed ID: 26971196
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
Krieger K; Heine J; Dumont P; Hellmann K
Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats.
Taenzler J; de Vos C; Roepke RKA; Heckeroth AR
Parasit Vectors; 2018 Nov; 11(1):595. PubMed ID: 30449272
[TBL] [Abstract][Full Text] [Related]
17. Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.
Colombo S; Leone F; Vercelli A; Cornegliani L
Vet Rec; 2012 Sep; 171(11):272. PubMed ID: 22791522
[TBL] [Abstract][Full Text] [Related]
18. Critically appraised topic for the most effective and safe treatment for canine generalised demodicosis.
Perego R; Spada E; Foppa C; Proverbio D
BMC Vet Res; 2019 Jan; 15(1):17. PubMed ID: 30616591
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats.
Taenzler J; de Vos C; Roepke RK; Frénais R; Heckeroth AR
Parasit Vectors; 2017 Jan; 10(1):30. PubMed ID: 28093080
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR
Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
